Application Nr Approved Date Route Status External Links
ANDA202984 2013-09-30 Oral RX Google , Wikipedia , PubMed , DailyMed , Raw OpenFDA , ECHA , ToxNet , JECFA , FAO , 21 CFR

Indications and Purposes

1 Indications And Usage Clonidine Hydrochloride Extended-Release Tablets Are Indicated For The Treatment Of Attention Deficit Hyperactivity Disorder (adhd) As Monotherapy And As Adjunctive Therapy To Stimulant Medications [see Clinical Studies ( 14)]. Clonidine Hydrochloride Extended-Release Tablets Are A Centrally Acting Alpha 2-Adrenergic Agonist Indicated For The Treatment Of Attention Deficit Hyperactivity Disorder (adhd) As Monotherapy Or As Adjunctive Therapy To Stimulant Medications. ( 1)

All Formulated Excipients (2 Total)

Name Structure Kind Function Status
1. Hypromelloses HYPROMELLOSES Unresolved
2. Magnesium Stearate MAGNESIUM STEARATE Molecular AF-Antifoaming (or defoaming) agent , MISC-Miscellaneous REG-Food additives for which a petition has been filed and a regulation issued.

Active Ingredients ( 1 Total)

Name Structure ZINC ID(s)
1. Clonidine Hydrochloride CLONIDINE HYDROCHLORIDE ZINC896484

Comments